Sponsors (3)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Allows TRICARE beneficiaries to choose to receive non‑generic maintenance prescription medicines through retail channels beginning October 1, 2026, and sets new contract conditions for the TRICARE pharmacy program that raise minimum pharmacy reimbursement, ban certain fees, require regular GAO audits of reimbursement and network access, and require a Defense Department implementation plan within 90 days of enactment.
The bill expands and protects retail access to maintenance medications for TRICARE beneficiaries and stabilizes pharmacy payments, but it raises program costs, risks uneven state‑level payments, and could prompt contractor responses or added administrative burdens that might reduce choice or increase overhead.
Veterans and other TRICARE beneficiaries can fill non‑generic maintenance medications at retail and alternative pharmacies beginning Oct 1, 2026, improving convenience and continuity of care for people with chronic conditions.
Retail and community pharmacies will receive minimum reimbursements (tied to actual WAC or NADAC) plus a dispensing fee and are protected from point‑of‑sale, retroactive, or hidden fees, which improves payment fairness and helps preserve local pharmacy participation and access—especially in rural areas.
Taxpayers, beneficiaries, and policymakers gain greater transparency and oversight through annual GAO audits and required contractor data/reporting, which can identify network adequacy and access gaps in underserved areas.
Taxpayers and the Department of Defense budget may face higher costs because guaranteed higher reimbursements and dispensing fees increase TRICARE pharmacy program spending.
Contractors could pursue other cost controls—such as narrowing pharmacy networks, tightening formularies, or reducing services—to offset higher payments, which may reduce choices and access for beneficiaries.
Tying certain reimbursement elements to State Medicaid dispensing fees can create uneven payments across states, advantaging pharmacies in high‑fee states and complicating uniform program budgeting and equity.
Introduced March 17, 2026 by Thomas Bryant Cotton · Last progress March 17, 2026